If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Download FREE Excerpt
8 Info Graphics
49 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Add to this increasing regulatory challenges, regional differences and the competitive nature of the oncology marketplace and it is easy to understand why GSM organizations to constantly assess their budgets and resource planning strategies to ensure a successful product launch.
Best Practices, LLC conducted primary research to identify valuable insights for Oncology-GSM leaders in budgeting and strategic planning. Specifically, this new report seeks to help GSM organizations understand the investment levels, marketing activities, timing and structures needed to successfully steer products and pipeline programs through the complex Oncology marketplace.
In addition, the report establishes meaningful benchmarks for the resource levels and the services scope of GSM organizations supporting Oncology products and programs.
Executives can use this study to compare their Oncology-GSM budget, staffing and services levels with industry averages and enhance their current practices.
Early Phases Take Greatest Percentage of GSM Spend: Large companies allocate 57% of total GSM funds, on average, to activities conducted during the early stages of product development, with Phase III accounting for more than half of that amount. Emerging companies, where development is the key focus, spend an average of 81% of GSM funds before launch, with the largest amount at the Preclinical phase.